DSPE-PEG1000-K237 is a PEG compound composed of DSPE and the KDR-targeting peptide (K237). K237 functionally disrupts the interaction between VEGF and KDR receptors, producing significant biological effects such as inhibiting angiogenesis and tumor growth. DSPE-PEG1000-K237 is applicable for drug delivery.
Target:
Liposome
* VAT and and shipping costs not included. Errors and price changes excepted